对抗SARS-CoV-2和变种的纳米医学方法
Han Zhang1, Yanbin Liu2, Zhuang Liu2
1College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China.
概括
纳米医学为应对正在演变的严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 流行病提供了创新解决方案. 这种方法利用纳米疫苗,纳米诱和纳米消毒剂来对抗当前和未来的病毒威胁.
科学领域:
- 纳米医学是一种纳米医学.
- 病毒学 病毒学
- 公共卫生 公共卫生
背景情况:
- 由严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 引起的全球流行病继续构成重大公共卫生和经济挑战.
- 病毒突变导致更易传播和免疫逃避菌株,导致再感染率增加.
- 对于针对SARS-CoV-2及其新兴变种的先进,安全和有效的对策非常需要.
研究的目的:
- 审查纳米医学的最新进展,以应对SARS-CoV-2及其变体.
- 突出纳米疫苗,纳米诱和纳米消毒剂的潜力.
- 探索流行病管理策略对未来公共卫生危机的适用性.
主要方法:
- 对针对SARS-CoV-2的纳米医学应用现有文献的综述.
- 对纳米疫苗,纳米诱和纳米消毒剂开发的分析.
- 从正在进行的流行病中综合了解未来的准备.
主要成果:
- 纳米医学利用纳米尺度的特性来实现适应性和有效的SARS-CoV-2对策.
- 纳米疫苗,纳米诱和纳米消毒剂在对抗病毒进化方面表现有前途.
- 为当前的流行病开发的战略为未来的纳米医学应用提供了基础.
结论:
- 纳米医学为减轻SARS-CoV-2影响提供了一个强大而通用的平台.
- 纳米药物的开发对于应对当前的病毒菌株和为未来的流行病做准备至关重要.
- 跨学科的洞察力是推动纳米医学推进全球卫生安全的关键.
更多相关视频
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
2.8K
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
2.6K
相关概念视频
01:29Microorganisms in Medicine and Therapeutics
35
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
35
02:30siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K